Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23876)

• Formulation Name: Remdesivir 100mg/vial powder
• Company: Gilead Sciences

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Remdesivir	(DMBFZ6L)	Coronavirus Disease 2019 (COVID-19)	1D6Y	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Betadex sulfobutyl ether sodium	(E00589)	66577045	Solubilizing agent
Hydrochloric acid	(E00015)	313	Acidulant
Sodium hydroxide	(E00234)	14798	Alkalizing agent